Contrasting Clinical Implications of NRAS Vs. KRAS Mutations in AML - Only KRAS Mutations Are Associated with Adverse Outcome
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-202833
Abstract: Introduction: Acute myeloid leukemia (AML) is a genetically and clinically heterogenous malignancy with highly prevalent structural alterations and less common sequence variants in children and adolescents. NRAS and KRAS mutations are the most prevalent mutations… read more here.
Keywords: risk; nras kras; kmt2a aml; g12 g13 ... See more keywords